Fiche centre
St. Vincent's Hospital
Fitzroy — Australia
Essais liés3clinical trials
VilleFitzroylocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05481879
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Rituximab | SEP | Phase 3 | NCT00004179 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | COMPLETED |
| DYNE-101 | Myopathies | Phase 1/2 | NCT05481879 | ACHIEVE — Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 | ACTIVE_NOT_RECRUITING |
| iVEAcare Neuromodulation System | Épilepsie | Non applicable | NCT07640191 | iVEAcare-FS — Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy | RECRUITING |